TELOGEN EFFLUVIUM
Clinical trials for TELOGEN EFFLUVIUM explained in plain language.
Never miss a new study
Get alerted when new TELOGEN EFFLUVIUM trials appear
Sign up with your email to follow new studies for TELOGEN EFFLUVIUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Millet seed supplement shows promise for hair loss in women
Disease control CompletedThis study tested whether millet seed extract capsules can reduce hair shedding in women with telogen effluvium, a common temporary hair loss condition. Sixty women took either the millet seed supplement or biotin alone for 12 weeks. Researchers measured changes in hair density u…
Matched conditions: TELOGEN EFFLUVIUM
Phase: NA • Sponsor: Kasr El Aini Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Hair loss breakthrough? supplement shows promise in new study
Disease control CompletedThis 6-month study tested a daily drinkable supplement containing vitamins, minerals, and plant extracts in 106 women aged 18-40 with telogen effluvium (a common temporary hair loss). Half took the supplement, half took a placebo. Researchers measured hair density and growth cycl…
Matched conditions: TELOGEN EFFLUVIUM
Phase: NA • Sponsor: Olistic Research Labs S.L. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a shampoo stop hair loss? new study says maybe
Symptom relief CompletedThis study tested a special shampoo for people with hair loss from telogen effluvium or early male/female pattern baldness. 40 adults used the shampoo for 3 months. The goal was to see if it improved hair length and thickness. The study is now complete.
Matched conditions: TELOGEN EFFLUVIUM
Sponsor: Lacer S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Hair loss hope? study tests latanoprost acid in women
Symptom relief CompletedThis study tested whether applying a cosmetic ingredient called latanoprost acid to the scalp could improve hair growth in women aged 18-60 with female pattern hair loss or chronic telogen effluvium. Twenty-nine women used one of three strengths of the product daily for six month…
Matched conditions: TELOGEN EFFLUVIUM
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC